Gilead Sciences | GenomeWeb

Gilead Sciences

The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. 

Lasker Honorees

The Albert and Mary Lasker Foundation has announced this year's recipients of its prizes honoring basic and clinical research.

NEW YORK (GenomeWeb) – The Yale School of Medicine today said that it and Gilead Sciences have extended a research collaboration to identify the genetic and molecular bases of cancer.

NEW YORK (GenomeWeb News) – Cancer Genetics today announced that Gilead Sciences has selected it to provide clinical trial services and molecular profiling of chronic lymphocytic leukemia patients.

NEW YORK (GenomeWeb News) – SomaLogic, New England Biolabs, and Gilead Sciences are suing Enzymatics in federal court for patent infringement.

This story originally ran on Dec. 22.
By Adam Bonislawski

Gilead is funding up to $100 million to the collaboration, which is aimed at identifying new molecular targets for the development of new cancer treatments.

Movers & Shakers

Premium

Leroy Hood, Samuel Broder, Mark Velleca, Paul Beresford, Dino DiCamillo

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.